1-2 of 2
Junko Hirato
Close
Sort by
Journal Articles

Soluble IL-2 Receptor α Is a More Sensitive Diagnostic Biomarker Than β2 Microglobulin and Predicts Survival in Follicular Lymphoma: Retrospective Analysis of 305 Cases

Akihiko Yokohama, MD, PhD, Yoko Hashimoto, MD PhD, Shimizu Hiroaki, MD PhD, Akio Saito, MD, Yuri Miyazawa, MD PhD, Hirono Iriujijima, MD PhD, Kotaro Toyama, MD PhD, Takuma Ishizaki, MD PhD, Takeki Mitsui, MD PhD, Hiromi Koiso, MD PhD, Makiko Takizawa, MD, PhD, Takayuki Saito, MD PhD, Hiroshi Handa, MD PhD, Kayoko Murayama, MD PhD, Morio Matsumoto, Morio Sawamura, MD PhD, Hirokazu Murakami, MD PhD, Yoshihisa Nojima, MD PhD, Junko Hirato, MD PhD, Masaru Kojima, MD PhD, Norifumi Tsukamoto, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3034.
https://doi.org/10.1182/blood.V124.21.3034.3034
Published: 2014
Journal Articles

Prognostic Importance of Soluble Form IL-2 Receptor á (sIL-2Rá) and Its Relationship with Surface Expression of IL-2Rá of Lymphoma Cell in Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy: a Retrospective Analysis of 409 Cases.

Akihiko Yokohama, Yoko Hashimoto, Akio Saito, Hirotaka Nakahashi, Kohtaro Toyama, Hiromi Koiso, Takayuki Saito, MD, Hiroshi Handa, Hideki Uchiumi, Takahiro Jimbo, Kayoko Murayama, Morio Sawamura, Morio Matsumoto, Masamitsu Karasawa, Hirokazu Murakami, MD, Yoshihisa Nojima, Junko Hirato, Masaru Kojima, Norifumi Tsukamoto
Journal: Blood
Blood (2009) 114 (22): 1935.
https://doi.org/10.1182/blood.V114.22.1935.1935
Published: 2009